Financhill
Back

Clearside Biomedical Quote, Financials, Valuation and Earnings

Clearside Biomedical Price Quote

$1.11
+0.02 (+1.83%)
(Updated: November 12, 2024 at 5:55 PM ET)

Clearside Biomedical Key Stats

Sell
31
Clearside Biomedical (CLSD) is a Sell

Day range:
$1.06 - $1.15
52-week range:
$0.88 - $2.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.74
P/B ratio:
0%

Volume:
326.6K
Avg. volume:
1.2M
1-year change:
12.57%
Market cap:
$81.5M
Revenue:
$8.2M
EPS:
$-0.5

How Much Does Clearside Biomedical Make?

Is Clearside Biomedical Growing As A Company?

  • What Is Clearside Biomedical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.91%
  • What Is Clearside Biomedical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Clearside Biomedical Stock Price Performance

What Is Clearside Biomedical 52-Week High & Low?

Clearside Biomedical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Clearside Biomedical?

Is Clearside Biomedical Cash Flow Positive?

  • What Is CLSD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19.1M
  • What Is Clearside Biomedical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.4M
  • What Is Clearside Biomedical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.1M

Clearside Biomedical Return On Invested Capital

Data Unavailable

Clearside Biomedical Earnings Date & Stock Price

Clearside Biomedical Competitors

  • Who Are Clearside Biomedical's Competitors?
    Below is a list of companies who compete with Clearside Biomedical or are related in some way:
    • Biomea Fusion Inc (BMEA)
    • Crinetics Pharmaceuticals Inc (CRNX)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Viking Therapeutics Inc (VKTX)

Clearside Biomedical Dividend Yield

Clearside Biomedical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 25.93%
Revenue: -91.16% -28.85%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.86
Upside from Last Price: 437.35%

Major Shareholders

  • How many CLSD shares are owned by institutional investors?
    16.4M CLSD shares are owned by institutional investors
  • How many CLSD shares are owned by insiders?
    6.6M CLSD shares are owned by insiders